NEW YORK STOCK EXCHANGE, INC. · DVA
-17.21% · -$39.24 · Vol 2.7M
Live · updated 14:53:13 ET
DaVita Inc

DaVita Inc

Health Care
$188.75
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
DVA
DaVita Inc
Tue Aug 4 · last completed session · daily score · 21h old
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

74/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6/6 factors with data · Tue Aug 4 · last completed session · daily score · 21h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is DVA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading DVA catalysts
About DaVita Inc
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Listed since
1995
Employees
78K
Country
US

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$205.25
Day high
$208.53
Day low
$183.62
Previous close
$227.99
52W high
$240.96
-21.67% from high
52W low
$103.87
62% of range
Market cap
$14.6B
P/E
19.89×
EPS
$9.49
Beta
0.09
Shares out
64.2M
Volume
2.7M
3.38× rel vol
Avg volume
810K
VWAP
$189.59
Price history computed in-house
1W
-21.67%
1M
-19.92%
3M
-3.83%
1Y
+34.32%
YTD
+66.14%
SMA 50 $218.19 · below
SMA 200 $157.69 · above
52W position 62%

DVA overview

Receipt-backed holder profiles
Loading financial statements
Loading DVA Form 4 filings
Public disclosures

Congress activity in DVA

Federal contracts

DVA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DVA in this window.
Lobbying spend

DVA lobbying filings, year to date.

Registered lobbying filings matched to DaVita Inc.

$4.5M
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Medicare/Medicaid VeteransHealth Issues
Filing
$1.2M
DAVITA INC

DAVITA INC.

Apr 20, 2026
Filing
$1.1M
DAVITA INC

DAVITA INC.

Jan 20, 2026
Filing
$1.1M
DAVITA INC

DAVITA INC.

Jan 20, 2026
Loading news for DVA
Analyst ratings
Sovereign unlock shows live analyst consensus for DVA.
Options
Sovereign unlock shows live options positioning for DVA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.